Get started
Author

Anja Schneller

Observed name: A. Schneller
ORCID: 0000-0002-2668-2201
Observed ORCID: 0000-0002-2668-2201
OpenAlex ID: A5010420384
A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription
2019 · Ekaterini Platanitis, Duygu Demiroz, et al. · Nature Communications · 243
PDF
EGF Induces Migration Independent of EMT or Invasion in A549 Lung Adenocarcinoma Cells
2021 · Karin Schelch, Lisa Vogel, et al. · Frontiers in Cell and Developmental Biology · 36
PDF
CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1
2023 · Christina Pfeiffer, Alexander M. Grandits, et al. · Leukemia · 26
Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
2021 · Anja Schneller, Niklas Zojer, et al. · Haematologica · 10
PDF
P-104: Multi-omics data integration reveals molecular targets of carfilzomib resistance in multiple myeloma
2022 · Julia Huber, Alina Malyutina, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
CTPS1 Is a Novel Therapeutic Target in Multiple Myeloma That Synergizes with Inhibition of ATR, CHEK1 or WEE1
2022 · Christina Pfeiffer, Alexander Michael Grandits, et al. · Blood
P-157: Carfilzomib (CFZ) resistance is associated with significant deregulation of the BH3 family proteins in multiple myeloma (MM)
2022 · Anja Schneller, Arnold Bolomsky, et al. · Clinical Lymphoma Myeloma & Leukemia
P873: Carfilzomib Resistance Is Associated With Significant Deregulation of the Bh3 Family Proteins
2022 · A. Schneller, A. Bolomsky, et al. · HemaSphere
P864: Ctps1 Is a Novel Therapeutic Target in Myeloma - Selective Small Molecule Inhibition Delivers Single Agent Activity and Synergises With Atr Inhibition
2022 · C. Pfeiffer, P. Beer, et al. · HemaSphere
Works count: 9
Citation count: 316
H-index: 4
I10-index: 4
Year
Topic
Type